Given that a certain AIDS treatment drug is patented in South Africa, what are the pros and cons of Doctors without Borders smuggling generic AIDS treatment drugs from Brazil to South Africa at a much lower price? Generally, what are the implications of a breach of patent law? Is it lawful or immoral for some pharmaceutical companies to supply a limited amount of free drugs or cut-price drugs to certain countries under particular conditions?

ll. What are the pros and cons of the scenario below? 2. Generally, what are the implications ofthis action for patent law? 3. Is this lawful or moral? 4. Can patent law be immoral? Why? Synopsis: Doctors without Borders [M5F), a non-prot charity, smuggled generic AIDS treatment drugs from Brazil to treat patients in South Africa. This is an act of defiance. By importing generic drugs from Brazil, MSF infringed on GlaxoSmithKline and Boehringer Ingelheim patents. The South African constitution protects the rights to life and dignity, and by importing these drugs, MSF believed they were upholding these rights. Recall that patent infringement is a civil matternot a criminal one. These drugs are patented in South Africa, so there is no competition between companies to make and market these drugs in South Africa, and the drugs are too expensive for wider use. By importing these drugs from Brazil at much lower pricesin breach of the patent lawMSF challenged both the South African government and the pharmaceutical industry to allow generic drugs to be made more accessible. Some pharmaceutical companies supply a limited amount of free drugs or cutprice drugs to certain countries under particular conditions; however, they could do much more. They need to determine how they can allow other companies to manufacture drugs in competition to their own products so prices decrease in poor countries. Their lawyers need to nd a way of doing this that protects the patents they hold in rich countries. At the same time, governments must do more as even the costs of generic drugs are too high for the governments of most poor nations. Taxpayers in European nations and North America will have to pay the costs